Log In Get Started
Press Releases April 27, 2026 09:00 AM

Nasdaq Resumes Trading in American Rebel Holdings, Inc.

Nasdaq resumes trading of American Rebel Holdings stock after over a month-long halt

By Priya Menon AREB
Nasdaq Resumes Trading in American Rebel Holdings, Inc.
AREB

Nasdaq announced the resumption of trading for American Rebel Holdings, Inc. (AREB and AREBW) on April 27, 2026, after the trading halt that began on March 20, 2026. Investors can now buy and sell the company's stock and warrants again on the Nasdaq exchange.

Key Points

  • Trading of American Rebel Holdings' stock and warrants was halted on March 20, 2026.
  • Trading resumed on April 27, 2026, at 11:00 a.m. Eastern Time on Nasdaq.
  • Investors are encouraged to check the Nasdaq website or contact the company for further information.

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading will resume in American Rebel Holdings, Inc. (Nasdaq: AREB and AREBW) at 11:00 a.m. Eastern Time on April 27, 2026. Trading in the company’s stock and warrants was halted on March 20, 2026 at 7:50pm Eastern Time.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

Nasdaq Contact:

Nasdaq MarketWatch
[email protected]

NDAQO


Risks

  • The reasons for the previous trading halt are not stated, potentially indicating underlying uncertainties.
  • Resumption of trading after a halt can increase volatility and investor uncertainty.
  • Potential regulatory or company-specific issues that led to the halt could still impact stock performance.

More from Press Releases

Fiverr Announces First Quarter 2026 Results Apr 29, 2026 Nayax to Report 2026 Q1 Earnings on May 12, 2026 Apr 28, 2026 Xunlei Filed Its Annual Report on Form 20-F for Fiscal Year 2025 Apr 28, 2026 Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Apr 28, 2026 Syntec Optics (Nasdaq: OPTX) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock Apr 28, 2026